CD1d is an MHC class I-like membrane glycoprotein that presents lipid Ags to NKT cells. Despite intensive biochemical, genetic, and structural studies, the endogenous lipids associated with CD1d remain poorly defined because of the biochemical challenges posed by their hydrophobic nature. In this study, we report the generation of a protease-cleavable CD1d variant with a similar trafficking pattern to wild-type CD1d that can be purified in the absence of detergent and allows the characterization of the naturally associated lipids. In addition, we used soluble variants of CD1d that are secreted or retained in the endoplasmic reticulum (ER) to survey their acquired lipids. By using multiple mass spectrometry methods, we found that CD1d retained in the ER is predominantly loaded with the most abundant phospholipid in the cell, phosphatidyl choline, while the protease cleavable version of CD1d contains bound sphingomyelin and lysophospholipids in addition to phosphatidyl choline. The secreted soluble version of CD1d, in contrast, lacks detectable phosphatidyl choline and the only detectable associated lipid is sphingomyelin. The data suggest that, in the absence of infection or stress, CD1d molecules survey the ER, the secretory pathway, and the endocytic pathway, and accumulate the most abundantly available lipids present in these compartments.
(reviewed in Ref. 1) . There are five genes encoding CD1 proteins in humans, called CD1a, b, c, d, and e. CD1a, b, c, and e are more homologous to each other than they are to CD1d, and are referred to as Group 1 CD1 molecules. CD1d is the sole member of Group 2, and is the only CD1 species found in mice and rats.
Unlike MHC class I and class II glycoproteins, which bind to short peptides, CD1 molecules associate with lipids. The structural elements that comprise the peptide binding sites of MHC glycoproteins and the lipid binding site of CD1 molecules are similar, consisting of a pair of antiparallel ␣-helices overlaying an eight strand ␤-sheet, but in the case of CD1, the site is highly hydrophobic and can accommodate the convoluted hydrocarbon chains of a wide variety of lipids (2) (3) (4) (5) . Similar to the way peptide Ags can be recognized by MHC class I and class II-restricted T cells, antigenic lipids associated with CD1 molecules can be recognized by effector T cells (6, 7) . CD1d molecules also present autologous lipids to a subset of T lymphocytes, called NKT cells, that play a major role in initiating adaptive immune responses (8) . The element of the associated lipid that confers specificity to the T cell-CD1 interaction is generally, but not always, the hydrophilic head group.
There are two sites in the cell where CD1 molecules are believed to capture lipids. The first is the endoplasmic reticulum (ER), where lipid binding is facilitated by the microsomal triglyceride lipid transfer protein (MTP). Data in support of this has been reported for CD1d in both mice and humans, and for CD1b in humans (8 -10) . The second is the endocytic pathway. CD1 molecules, with the exception of CD1a, are equipped with tyrosinebased targeting motifs in their cytoplasmic domains that induce their internalization and subsequent recycling through late endosomes or lysosomes, and here lipid binding is also catalyzed by lipid transfer proteins, predominantly the saposins (11) (12) (13) (14) . Four saposins (A, B, C, and D) are generated from a precursor called prosaposin by lysosomal proteolysis, and they facilitate the degradation of a variety of glycolipids by removing or "lifting" them from the membrane, making them susceptible to the action of lysosomal glycosidases (15) . Saposin B has been shown to be the dominant saposin that mediates lipid binding to human CD1d molecules (12) , and saposin C functions in CD1b loading (14) . Other lysosomal lipid transfer proteins, such as GM2 activator protein (13) and Niemann-Pick Type C2 (16) have also been implicated in lipid binding to mouse CD1d. A role for CD1e has also been suggested in facilitating lipid binding by the other CD1 species in lysosomes (17) .
Our understanding of the mechanisms that generate peptides bound by MHC class I and class II molecules has been furthered considerably by analysis of the pools of associated peptides in normal or cultured cell lines. For example, MHC class I-associated peptides were shown to derive mostly from cytosolic proteins, while those associated with MHC class II were predominantly from the extracellular domains of plasma membrane proteins, exogenous soluble proteins, and even lysosomal proteins (18, 19) . This information generalized the principles governing Ag-processing pathways that arose from studies of the processing of specific protein Ags for T cell recognition. In the case of CD1 molecules, while considerable effort has been expended using a variety of antigenic lipids to investigate the mechanisms of lipid loading, there is little information on the normal profile of endogenous lipids associated with CD1 molecules that might similarly enhance our understanding of lipid loading principles. There is a technical difficulty in identifying such lipids in that detergents must be used to solubilize transmembrane proteins for purification, and detergents can induce lipid dissociation from CD1 molecules. To overcome this problem, a soluble, secreted version of mouse CD1d was produced that could be purified in the absence of detergents, and glycosylphosphatidylinositol was found to be the major bound lipid (20) . Using the same approach, soluble versions of human CD1d and CD1b proteins were made and the lipids associated with them were analyzed. Surprisingly, a single cellular phospholipid, phosphatidyl inositol (PI), was found to be associated with both CD1d and CD1b proteins (17) . The same lipid was found to be associated with soluble CD1d molecules retained in the ER by the addition of a KDEL sequence to its C terminus (17) . However, an intrinsic problem with using soluble CD1 molecules is that they do not have access to the endocytic pathway.
To allow analysis of the lipids associated with CD1 molecules that recycle through the endocytic pathway, we generated a version of human CD1d that could be proteolytically cleaved to produce a soluble molecule. In this study, we present mass spectrometric (MS) analyses of the lipids bound to the recycling form of CD1d as well as a re-analysis of lipids purified from soluble secreted CD1d and soluble ER-retained CD1d. The data show that all three versions are predominantly associated with the dominant lipids present or produced in the compartments to which they have access.
Materials and Methods

Plasmids, cell lines, and Abs
The .221.ERCD1d and .221.secCD1d cell lines have been described previously (17) . To construct a cDNA encoding protease-cleavable CD1d (pclCD1d), an oligonucleotide encoding 12 amino acids (QLYQGKKPD VSP) derived from the proGILT sequence was inserted between the luminal and transmembrane domains of CD1d by PCR, and the cDNA was cloned into the pIRESneo vector (Clontech). The.221.pclCD1d cell line was generated by electroporation as previously described (21) . The mouse mAbs to human CD1d, CD1d51 (51.1.3) (22) , and D5 (22) , were gifts from Dr. Steven Porcelli (Albert Einstein College of Medicine, New York, NY) and Dr. Steven Balk (Harvard Medical School, Boston, MA), respectively. The rabbit anti-calnexin Ab was a gift from Dr. Ari Helenius (ETH Zurich, Zurich, Switzerland). Alexa 488-conjugated goat anti-rabbit IgG secondary Ab and Alexa 594-conjugated goat anti-mouse IgG secondary Ab were from Invitrogen, and FITC-conjugated mouse anti-Lamp1 mAb was from BD Biosciences. Rabbit anti-ERp57 serum and the anti-DM mAb K589 were described previously (21, 23) .
Affinity purification
Purification of ERCD1d and secCD1d was performed as described previously (17) . In brief, for secCD1d, cell culture supernatants were filtered before affinity purification. For ERCD1d, .221.ERCD1d cells (10 10 ) were frozen and thawed on ice in 10 mM Tris HCl (pH 7.4) containing phenyl methyl sulfonyl fluoride (0.5 mM) and iodoacetamide (5 mM). After centrifuging at 1000 ϫ g for 10 min to remove nuclei and debris, the supernatants were sonicated briefly and centrifuged at 100,000 ϫ g for 1 h at 4°C to pellet the membranes. The supernatants were then used for affinity purification using the anti-CD1d mAb CD1d51 coupled to Biogel A15m (Bio-Rad), eluting with 3.5M MgCl 2 . For purifying papain-cleaved pclCD1d and HLA.A2 proteins, .221.pclCD1d or .221.A2 cells (10 10 ) were frozen and thawed as described above and pelleted at 1000 ϫ g for 10 min to remove nuclei. After resuspending in 0.15 M NaCl containing 2 mM cysteine, the membranes were digested with 8 U/ml papain (ICN) at 37°C for 5 min before adding iodoacetamide to 10 mM to stop the reaction. Insoluble material was removed by centrifugation at 100,000 ϫ g for 90 min. The supernatant was loaded onto a CD1d51 affinity column or w6/32 affinity column for CD1d and HLA.A2 purification, respectively. The specific columns were washed with TBS (10 mM Tris (pH 7.4), 150 mM NaCl) and eluted with 3.5 M MgCl 2 . The fractions containing protein were pooled and dialyzed against 50 mM ammonium acetate. Protein purity was ascertained by SDS-PAGE and Coomassie Blue and silver staining.
Lipid extraction and mass spectrometry
Total lipids were extracted by a modified Bligh and Dyer method (24) . In brief, purified CD1d protein was mixed with 3.75 volumes of chloroformmethanol (1/2) and vortexed three times for 1 min each. The extract was kept at room temperature for 1 h before 1.25 volumes each of chloroform and aqueous 0.88% KCl were added. The mixture was again vortexed three times for 1 min each time and then centrifuged at 2500 rpm for 5 min to separate the organic and aqueous phases. The lower organic phase was retrieved and dried under a stream of nitrogen gas and the dried lipids were redissolved in chloroform-methanol (1/1). Linked-scan tandem quadrupole mass spectrometry was performed for detection of phospholipids by the methods described by (25) , using a Waters Quattro-II triple quadrupole mass spectrometer (Waters) in the nanospray mode with fused silica nanospray capillaries (New Objectives). Linked scan monitoring of parents of the m/z 241 ion was used in the negative mode to specifically detect PI species. Phosphatidylcholine (PC) and sphingomyelin were detected in the positive ion mode by monitoring parents of the m/z 184 ion. Phosphatidylethanolamine (PE) and phosphatidylserine (PS) were detected in positive mode by monitoring neutral losses of 141D and 185D, respectively. PS and PE were also detected in the negative ion mode by monitoring the neutral losses of 196D and 87D, respectively. The lipid samples were also analyzed by MALDI-TOF MS using the method of Schiller et al. (26) using a Waters MALDI L/R-TOF instrument (Waters) and a LCQ ion trap mass spectrometer (Thermo Finnigan) to nonselectively detect a wide range of lipids that might be present.
Immunofluorescence microscopy
Immunofluorescence was performed as previously described (27) . CD1d-expressing HeLa cells and HeLa transfectants were overlayed on coverslips and fixed in 3.7% formaldehyde. After permeablization in 0.1% saponin, the cells were stained by indicated Abs and mounted on slides in Mowiol 4 -88 (Calbiochem). The cells were examined using a Zeiss Axioplan2 microscope or a Leica S2 confocal microscope and images were collected by Openlab (Improvision) and Leica software.
Percoll gradient separation of membrane fractions
Percoll gradient separation was performed as previously described (28) . Cells were harvested and washed in homogenization buffer (10 mM triethanolamine, 10 mM acetic acid, 1 mM EDTA, 250 mM sucrose (pH . 2, A and B) .
7.4)
). They were then disrupted with a ball bearing homogenizer and nuclei were removed by centrifugation at 1000 ϫ g for 5 min. The postnuclear supernatant was mixed with 1.1 volumes of homogenization buffer and 0.6 volumes of Percoll stock (90% Percoll in homogenization buffer, SigmaAldrich) and underlaid with 27.6% Nycodenz (Sigma-Aldrich). The gradient mix was centrifuged at 17,500 rpm (Rotor SW41Ti at 4C) for 1 h and fractions were collected from the top of the gradient.
Results
Generation and characterization of protease-cleavable CD1d
To identify lipids associated with CD1d that recycles through endocytic pathway, we constructed a CD1d variant (pclCD1d), which has a short peptide of 12 amino acids (QLYQGKKPD-VSP) inserted between the extracellular, membrane proximal, ␣ 3 domain and the transmembrane domain (Fig. 1A) . This peptide corresponds to a site in the pro-form of ␥ IFN-inducible Lysosomal Thioreductase (GILT) that is proteolytically cleaved during the maturation of GILT in lysosomes (29) , and was expected to allow the isolation of recycling CD1d without the use of detergents (17) . Constructs encoding soluble human CD1d molecules (Fig. 1A) have been previously described (17) . Secreted secCD1d consists of only the ectodomain associated with ␤ 2 m. ER-retained ERCD1d contains the ectodomain of human CD1d attached to an ER-retrieval signal, KDEL. Pulse-chase experiments showed that ERCD1d remained sensitive to digestion with endoglycosidase H, consistent with ER retention, whereas secCD1d was secreted into the culture supernatant (Ref. 17 and data not shown). pclCD1d, in contrast, acquired endoglycosidase H-resistance in a similar manner to wild-type CD1d (supplemental Fig. 4 , 5 compare with data in Ref. 27 ). Transient transfection of HeLa cells with the three CD1d constructs followed by immunofluorescence analysis confirmed that they localized to the desired subcellular compartments. Although secCD1d had a weak and diffuse intracellular pattern 5 The online version of this article contains supplemental material. (data not shown), ERCD1d was exclusively in the ER based on its colocalization with the ER resident protein, calnexin (Fig.  1B) . Like the wild-type CD1d protein (21), pclCD1d was found both on the cell surface and within lysosomes based on costaining with the lysosomal marker Lamp1 (Fig. 1C) . This was confirmed by subcellular fractionation using Percoll density gradients of the human MHC class I-negative B cell line .221 transfected with the same construct, detecting the pclCD1d by Western blotting (Fig. 1D) . The lighter fractions contain broad, heavily glycosylated, CD1d H chain bands, consistent with the CD1d molecules having traversed the Golgi apparatus. This indicates that they are associated with the plasma membrane, which cosediments with ER in Percoll gradiernts. Our original hope was that natural cleavage in lysosomes would yield a soluble CD1d molecule that we could purify. However, though some probable cleaved product was seen in the lysosomal fraction, at the bottom of the gradient, this was not a significant fraction of the total expressed protein.
Purification of the soluble CD1d proteins
For purification of pclCD1d, membranes were isolated from .221.pclCD1d cells. pclCD1d was released by papain cleavage and affinity purified using the CD1d51 mAb as described in the Materials and Methods. As a control, papain-cleaved HLA-A2 was purified from .221.A2 cells. Affinity chromatography using the anti-HLA class I mAb w6/32 was used to purify the HLA-A2 molecules. ERCD1d was released from .221.ERCD1d cells by freezethaw followed by sonication of postnuclear supernatants and purified by affinity chromatography (17) . secCD1d was purified from the tissue culture supernatants of .221.secCD1d cells, as previously described (17) . The purified proteins were subjected to SDS-PAGE to determine their purity, and a Coomassie Bluestained gel is shown in Fig. 2 . As expected, secCD1d had a slightly higher M r than the ERCD1d, consistent with late stage glycosylation steps occurring along the secretory pathway, while the pclCD1d band was smeared in addition to the M r shift, perhaps consistent with progressive deglycosylation occurring during repeated recycling between the cell surface and late endosomes and lysosomes. Associated ␤ 2 m was allowed to run off the gels to increase the resolution of the H chain bands. A similar SDS-PAGE analysis of purified HLA-A2, shown in supplemental Fig. 1 , revealed a single band corresponding to the cleaved A2 H chain.
Identification of CD1d-associated lipids
Bound lipids were extracted from 50 g of the purified proteins using chloroform/methanol as described in Materials and Methods, and subsequently analyzed by MS and linked scan MS/MS. Fig. 3 shows the results for pclCD1d. Fig. 3A shows the total profile obtained by MALDI-TOF, while Fig. 3B shows the result of linked scan analyses for parental ions of phosphocholine and sphingomyelin with choline daughter ions using a Quattro-II triple quadrupole mass spectrometer. PC with a range of hydrocarbon chain lengths was the dominant lipid detected, although sphingomyelin was also detected at lower levels. Analysis of the cholinecontaining lipids present in total lipid extracts from .221 cells and the FBS in the tissue culture medium used to grow the .221.ERCD1d cells indicated that the lipids isolated from pclCD1d were derived from the cells and not the tissue culture medium (supplemental Fig. 2 , for example, compare the relative abundance of 34:1 PC over 32:1 PC in Fig. 3B to supplemental Fig. 2, A and  B) . Further analysis showed that lysophospholipids were also associated with pclCD1d (Fig. 3C ). These were lyso PC, lyso PS, and lyso PE. The molecular species resembled the lysophospholipid species from .221 cells rather than those found in FBS, for example in the ratio of 18:1a to 18:2a ions (highlighted in Fig. 3C ), indicating that they were derived from the .221.pclCD1d cells (compare the highlighted peaks in Fig. 3C to the indicated peaks in supplemental Fig. 2, A and B) . Using specific parental ion scans and the neutral loss scans in both negative and positive modes of electrospray ionization, we did not detect significant amounts of other phospholipids. No significant PC, PE, PS, lysophospholipids, or sphingomyelin was detectable when the same amount of papaincleaved, affinity-purified HLA-A2 was subjected to identical analyses (supplemental Fig. 1C) .
The previous studies with the soluble ER-retained and secreted versions of CD1d indicated that PI was the dominant associated lipid (17) . Because we did not detect any PI or PI derivatives associated with the recycling pclCD1d version of CD1d, we performed an independent re-analysis of the lipids associated with ERCD1d and secCD1d. Fig. 4 shows the results for the lipids associated with ERCD1d. In the new analysis, we failed to detect PI. In fact, PC was the dominant phospholipid found, confirmed by a choline daughter ion scan (precursors of m/z 184). In contrast to the pclCD1d-associated lipids, no sphingomyelin was detected. As we observed for pclCD1d, the profile of the PC molecular species was more similar to that of .221 cells than that isolated from FBS (supplemental Fig. 2 ). Fig. 5 shows an analysis of the lipids associated with secCD1d. In this case, MALDI/TOF analysis indicated that the dominant lipid was sphingomyelin (Fig. 5A) , which was confirmed by a choline daughter ion search (Fig. 5B) . The dominant sphingomyelin species identified had the same carbohydrogen composition as that from pclCD1d sample (d18:1/24:1). Notably, this is the most abundant sphingomyelin species synthesized by mammalian cells (30) . PE was detectable at low levels in association with both ERCD1d and pclCD1d in some analyses (data not shown), but the lysophospholipids were only detectable in pclCD1d preparations.
Given the previous results with ERCD1d and secCD1d (17) we were surprised that in these studies no PI or its derivatives were found to be associated with any of the three preparations of CD1d. This was not due to an inability to detect PI, for example because of low sensitivity of detection or because of the extraction or ionization conditions. We used a variety of approaches, including varying lipid extraction methods, different chromatographic techniques for lipid purification, and multiple instruments for MS, including MALDI/TOF, Quattro II Tandem quadrupole and LCQ ion trap instruments (data not shown). Furthermore, trace amounts (3-5 ng or 4 -6 pmol) of plant-derived PI (34:3, m/z 833.5) were readily detectable when added as an internal standard to the lipid samples (supplemental Fig. 3 ). Our calculations suggest that even if the loading efficiency of CD1d is low (10%), and the extraction efficiency suboptimal (50% recovery), PI should be readily detectable. The identification of PI as a CD1d-associated lipid in the previous work remains unexplained.
Discussion
The three derivatives of CD1d studied here have differential access to intracellular environments. ERCD1d is restricted to the early secretory pathway by the presence of an ER retention signal at its C terminus. The KDEL sequence is actually a retrieval motif that binds to a receptor that recovers proteins bearing the motif from the cis-Golgi. secCD1d assembles with ␤ 2 m in the ER, passes through the Golgi apparatus and trans Golgi network, and is secreted from the cell. Finally, the pclCD1d construct was designed to have access to the endocytic pathway and to behave as much like the native CD1d molecule as possible. It was expected to assemble in the ER, travel through the Golgi apparatus to the plasma membrane, and then to constitutively recycle through the endocytic pathway. The presence of pclCD1d in the endocytic pathway was confirmed by immunofluorescence and subcellular fractionation (Fig. 1) , and a variety of immunofluorescence and biosynthetic studies confirmed that all three species behaved as expected (Fig. 1, Ref. 17 , and data not shown). Based on this, the lipids bound by the three species should reflect the environments to which they have access. Because of the relative insensitivity of the MS approaches used in these studies, and because the hydrocarbon chains are the dominant feature of lipids governing their binding to CD1 molecules, one might simplistically expect the lipids observed to be the dominant ones present unless specific loading mechanisms dictate otherwise. In the earlier studies (17), the surprising finding was that PI was the dominant lipid found in both secreted and ER-retained species. However, in this study we have failed to confirm those findings and the simplistic expectations appear to have been met for ERCD1d and pclCD1d. However, the finding that sphingomyelin was the dominant lipid-associated with secCD1d was unexpected.
The only readily detectable lipid associated with ER-retained CD1d molecules was PC, although occasional experiments revealed a small amount of PE. PC is the most abundant phospholipid found in eukaryotic cells, and given that sphingomyelin is absent from the ER, it is perhaps to be expected that this is the species associated with ERCD1d. The terminal stages of sphingomyelin synthesis occur in the Golgi apparatus (31), and therefore there are no topological constraints that could prevent the acquisition of sphingomyelin by secCD1d. However, if PC is acquired by all CD1d molecules in the ER before their release into the secretory pathway, it would seem highly unlikely that it would be replaced so efficiently during secretion that none would be detected. One possible explanation is that most of the CD1d molecules escaping the ER are devoid of associated lipids, and sphingomyelin is readily bound during transport or from FBS following secretion. Unfortunately, the experimental systems used did not allow us to quantify the various lipid species isolated, and we cannot estimate the fractional occupancy of either the secreted or ER-retained CD1d. It is conceivable that secCD1d assembles and leaves the ER in a predominantly lipid-free form, but that the ERretained version accumulates PC during the prolonged period it spends recycling between the ER and cis-Golgi: the half-life of sec CD1d is Ͼ20 h (Ref. 17 and data not shown). There are no data to indicate how efficiently MTP catalyzes lipid loading in the ER, and in fact one view is that it catalyzes the binding of the antigenic lipid ␣-galactosylceramide in the endocytic pathway and not in the ER (32) , which is entirely consistent with empty CD1d molecules being assembled and secreted. Alternatively, PC binding in the ER may be efficient but lipid exchange factors present in the secretory pathway after the cis-Golgi preferentially exchange sphingomyelin for PC. These two hypotheses are not mutually exclusive; there may be a factor within the Golgi or trans Golgi network that preferentially loads empty CD1d molecules with sphingomyelin. We know of no candidates for such a factor, but this possibility certainly needs to be explored. Determining the true CD1d lipid loading efficiency and establishing whether CD1d can leave the ER without a bound endogenous lipid will shed light on whether lipids bound in the ER play a chaperone-like role in CD1d assembly and transport, a role clearly played by endogenous peptides or the invariant chain in the MHC class I and class II systems, respectively. Temporary retention of secCD1d in the ER by a trafficking inhibitor, such as brefeldin A, combined with quantitative MS analysis, might be used to address this question.
Recycling, membrane-associated pclCD1d molecules are associated with a combination of the species bound to the two soluble variants. Both sphingomyelin and PC were detected, although PC is dominant. Given the lack of PC in the secreted version, it seems unlikely that the PC present in pclCD1d was acquired in the ER. It is perhaps more likely that the lipids associated with this species were accumulated during continuous recycling through the endocytic pathway, although differences in the susceptibility of soluble and membrane-bound CD1d molecules to exchange cannot be excluded. Our earlier in vitro data describing the role of saposins in lipid loading indicated that the binding of a phospholipid, in that case a biotinylated derivative of PE, was catalyzed as efficiently by saposin B as was the binding of a similar derivative of ␣-galactosylceramide (12) . In addition, the published structures of CD1-lipid complexes do not support a major role for lipid head groups in the regulating the specificity of lipid binding (2) (3) (4) (5) .
The finding most consistent with accumulation of lipids in the endocytic pathway by pclCD1d molecules is that lysophospholipids were found to be associated with them. Lysophospholipids are generated in the lysosome during lipid degradation by the action of phospholipases (33) . How stable the interaction might be between CD1d and lysophospholipids, which bear a single fatty acyl chain, is unclear. However, recognition of CD1d-associated lysophospholipids by noninvariant NKT cells has been described, arguing for a potential in vivo function for such an association (34, 35) . Notably, no detectable lysolipids were found in association with either the ER-retained or secreted forms of CD1d. The absence of lysophospholipids associated with secCD1d, which was isolated from tissue culture supernatants, is perhaps the strongest evidence that the lysophospholipids were indeed acquired by pclCD1d in the endocytic pathway.
The detection of PC and sphingomyelin in pclCD1d is consistent with their particularly high abundance in mammalian cells. In fact, PC, PE, and sphingomyelin are the three most abundant lipid species in mammalian membranes. However, only PC and sphingomyelin were detectable at significant levels. Interestingly, most PC and sphingomyelin species are asymmetrically located in the luminal/extracellular leaflet of the bilayer (31, 36). Although it is not known whether a lipid transfer protein might be functioning in the Golgi complex that is involved in loading sphingomyelin, all of the identified lipid transfer proteins, MTP, saposin, GM2 activator, and Niemann-Pick C proteins are luminal soluble proteins that are likely to preferentially extract lipids from the luminal leaflet.
Several recent studies on the purification and identification of CD1 natural ligands, as well as in vitro lipid loading studies and structural studies have shown that PC is naturally associated with purified mouse CD1d and human CD1b secreted from mammalian or insect cells (3, 5) . Different species of PC can be loaded into human CD1d and other group I CD1 molecules and recognized by T cells (37) . Sphingomyelin was also isolated from secreted mouse CD1d (3) and can be loaded onto human CD1d and other human group I CD1 molecules in vitro (38) . Although we can readily detect various PC species in the ER-retained version of CD1d, it is surprising that sphingomyelin was almost exclusively found in secreted CD1d. Although CD1b and CD1d could acquire different endogenous lipids along secretory pathway, there are substantial differences between our protein purification and mass spectrometry methodologies and that used for human CD1b (5) . Furthermore, during the MS/MS analysis of CD1b, which relied on MS of the native protein with the bound ligand, sphingomyelin could be present but less efficiently dissociated from the protein/lipid complex by collisional activation and therefore less readily detected than PC. There was still significant complete protein/lipid complex present after collisional activation of the native protein MS analysis (5) and it would be interesting to investigate whether higher energy collisional activation MS/MS of extracted lipids could identify remaining complexed sphingomyelin. Interestingly, in addition to PC some sphingomyelin could be detected in association with soluble mouse CD1d secreted from insect cells, which lack endogenous sphingomyelin. The sphingomyelin in this situation was almost certainly bound postsecretion from FBS-derived lipids in the tissue culture medium.
In the data reported in this study the dominance of sphingomyelin and the absence of PC associated with secCD1d makes it unlikely that loading is exclusively occurring in the culture supernatants. The level of PC in FBS is high whereas high levels of sphingomyelin were not readily detectable (supplemental Fig. 2 ). Unless CD1d molecules preferentially bind sphingomyelin, or specific exchange factors are secreted into the tissue culture supernatant, one would expect that PC would be the dominant lipid associated with secCD1d. However, at the moment is must be regarded as unproven that sphingomyelin actually binds to secCD1d within the secretory pathway.
Earlier studies of the endogenous peptides associated with MHC class I and class II molecules helped define the mechanisms of peptide generation, and the data we have generated here helps to define the cellular compartments where lipid binding to CD1d can occur. The dominance of PC associated with ER-retained CD1d is consistent with it being a major lipid in ER membranes, and the absence of sphingomyelin is consistent with the lack of this lipid in the ER. The association of sphingomyelin with secCD1d supports the idea that binding might occur in the secretory pathway, with the caveat that binding in the tissue culture medium may be at least in part responsible. Although the physiological significance of the observations using the soluble CD1d molecules is unclear, the detection of PC, sphingomyelin, and lysophospholipids associated with pclCD1d supports preconceptions derived from earlier studies examining the binding of antigenic lipids by CD1 molecules (1); lipid loading and/or exchange predominantly occurs during recycling through the endocytic pathway.
